Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Pain

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejpain.2005.12.001PMID 16426877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.

  2005cited by this paper
• Opioids in renal failure and dialysis patients.

  2004influential reference
• Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial.

  2003cited by this paper
• [Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain].

  2003cited by this paper
• Pain in hemodialysis patients: prevalence, cause, severity, and management.

  2003cited by this paper
• Analgesia in patients with ESRD: a review of available evidence.

  2003cited by this paper
• Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry.

  2003cited by this paper
• Pharmacokinetics of Tramadol in a Hemodialysis Patient

  2002cited by this paper
• Methadone is poorly removed by haemodialysis.

  1999cited by this paper
• Nondialyzability of fentanyl with high-efficiency and high-flux membranes.

  1998cited by this paper
• Removal of morphine but not fentanyl during haemodialysis.

  1997cited by this paper
• Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites.

  1990influential reference
• Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites.

  1989cited by this paper
• Pharmacokinetics and pharmacodynamics of codeine in end‐stage renal disease

  1988cited by this paper
• Morphine Pharmacokinetics in Renal Failure

  1987cited by this paper
• Effects of Renal Insufficiency on the Pharmacokinetics and Pharmacodynamics of Opioid Analgesics

  1987cited by this paper
• Buprenorphine in end stage renal failure

  1985cited by this paper
• Mandatory sublingual buprenorphine for postoperative pain

  1984cited by this paper
• The metabolism and excretion of buprenorphine in humans.

  1984cited by this paper
• Effect of hemodialysis on propoxyphene and norpropoxyphene concentrations in blood of anephric patients *

  1980cited by this paper
• The metabolism of phenolic opiates by rat intestine.

  1977cited by this paper
• Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

  1977cited by this paper
• The role of the gut in the metabolism of strong analgesics.

  1976cited by this paper

• Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain Clinicians

  2025cites this paper
• Renal Implications of Kappa Opioid Receptor Signaling in Sprague-Dawley Rats.

  2025cites this paper
• Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain

  2025cites this paper
• Identifying Barriers and Facilitators to Pain Management With Buprenorphine for Patients With Kidney Failure: A Thematic Analysis of Interviews With Key Partners

  2025cites this paper
• Case Report: Buprenorphine for Palliation in a Patient with End Stage Renal Disease

  2024cites this paper
• Buprenorphine as a unique opioid analgesic – an overview ofexperimental and clinical data

  2024cites this paper
• Opioids and the Kidney: A Compendium

  2023cites this paper
• Buprenorphine for Chronic Pain Management: a Narrative Review

  2023cites this paper
• PAIN MANAGEMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE

  2022cites this paper
• A Review of the Safety of Buprenorphine in Special Populations.

  2022cites this paper
• Chronic Pain in the Elderly: Mechanisms and Perspectives

  2022cites this paper
• The use of opioid receptor agonists and antagonists in the treatment of patients with advanced chronic kidney disease and undergoing renal replacement therapy

  2022cites this paper
• Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain

  2021cites this paper
• Opioids in Hemodialysis Patients.

  2021cites this paper
• Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids.

  2021cites this paper
• Opioids for chronic pain management in patients with dialysis-dependent kidney failure

  2021cites this paper
• Pharmacologic Considerations for Opioid Use in Kidney Disease.

  2021cites this paper
• Pain management in patients with chronic kidney disease and end-stage kidney disease

  2020cites this paper
• Opioid Therapy for Pediatric Cancer Pain

  2020cites this paper
• The Role of Opioids in Pain Management in Elderly Patients with Chronic Kidney Disease: A Review Article

  2020cites this paper
• A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain

  2020cites this paper
• TCRM_A_262843 821..837

  2020cites this paper
• Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists

  2020cites this paper
• Pain syndrome in patients receiving chronic program dialysis

  2019cites this paper
• Transdermal buprenorphine patch: Potential for role in management of opioid dependence.

  2019cites this paper
• Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients

  2019cites this paper
• Renal impairment and analgesia: From effectiveness to adverse effects

  2019cites this paper
• Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management.

  2019cites this paper
• Chronic Pain Management in the Elderly.

  2019cites this paper
• 尿毒症性細小動脈石灰化症（カルシフィラキシス）の難治性皮膚潰瘍部疼痛に対して，ブプレノルフィンによる鎮痛が奏功した1例

  2018cites this paper
• Buprenorphine and pain treatment in pediatric patients: an update

  2018cites this paper
• Management of pain in end‐stage renal disease patients: Short review

  2018cites this paper
• Pain Management in Pediatric Chronic Kidney Disease.

  2018cites this paper
• Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option

  2018cites this paper
• Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease

  2018cites this paper
• Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain

  2017cites this paper
• Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review

  2017cites this paper
• Buprenorphine—an atypical opioid: All you need to know

  2017cites this paper
• C-Homomorphinan Derivatives as Lead Compounds to Obtain Safer and More Clinically Useful Analgesics.

  2017cites this paper
• Pain Management in CKD: A Guide for Nephrology Providers.

  2017cites this paper
• Opioid Use in Chronic Pain Patients with Chronic Kidney Disease: A Systematic Review

  2017cites this paper
• Analgesia for Moderate Chronic Non-Cancer Pain : Low Dose Transdermal Buprenorphine A Novel Option in Mexico

  2016cites this paper
• The switch from buprenorphine to tapentadol: is it worth?

  2016cites this paper
• Breakthrough Pain Associated with a Reduction in Serum Buprenorphine Concentration during Dialysis.

  2016cites this paper
• Prescribing for patients on dialysis.

  2016cites this paper
• Buprenorphine for treating cancer pain.

  2015cites this paper
• Safety and Efficacy of Buprenorphine Patch in the Management of Chronic Pain

  2015cites this paper
• Buprenorphine for Cancer Pain

  2015cites this paper
• An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms

  2015cites this paper
• Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain

  2015cites this paper
• Therapy of Cancer-Related Pain and Cancer Therapy-Related Pain

  2015cites this paper
• Buprenorphine for neuropathic pain in adults.

  2015cites this paper
• The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review

  2015cites this paper
• Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.

  2014cites this paper
• Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study

  2014cites this paper
• Pain in Chronic Kidney Disease: A Scoping Review

  2014cites this paper
• Original article Is buprenorphine transdermal patch equally safe andeffectiveinyoungerandelderlypatientswith osteoarthritis-related pain? Results of an age-group controlled study

  2014cites this paper
• Management of acute and post-operative pain in chronic kidney disease

  2013cites this paper
• Methadone and buprenorphine prescribing in the palliative care population

  2013cites this paper
• Understanding individual reactions to opioids in pain management

  2013cites this paper
• Efficacy and safety of transdermal buprenorphine in the management of children with cancer‐related pain

  2013cites this paper
• Methadone and Buprenorphine Analgesia in Older Patients

  2013cites this paper
• Buprenorphine Analgesia in Chronic Pain

  2013cites this paper
• Buprenorphine: Side Effects and Tolerability

  2013cites this paper
• Buprenorphine.

  2013cites this paper
• Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain.

  2012cites this paper
• Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain.

  2012cites this paper
• Pharmacokinetics of transdermal buprenorphine patch in the elderly

  2012cites this paper
• Buprenorphine in the management of persistent pain – update review

  2011cites this paper
• A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: A European Palliative Care Research Collaborative opioid guidelines project

  2011cites this paper
• Transdermal opioids for cancer pain

  2011cites this paper
• Valoración de la efectividad de una pauta analgésica con buprenorfina transdérmica en pacientes afectos de isquemia arterial crónica evolucionada de las extremidades inferiores: perfil genético

  2011cites this paper
• Health Reference Center Academic Print

  2011cites this paper
• Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

  2011cites this paper
• Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy.

  2011cites this paper
• The use of major analgesics in patients with renal dysfunction.

  2010cites this paper
• Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

  2010influential citation
• Therapie perioperativer Schmerzen in der Kinderurologie

  2009cites this paper
• Systemic opioid and chronic pain

  2009cites this paper
• [Therapy of perioperative pain in pediatric urology].

  2009cites this paper
• Management of pain in chronic kidney disease

  2009cites this paper
• Interindividual variability of drug transporters: Impact on opioid treatment in chronic renal failure

  2009cites this paper
• Pain therapy.

  2009cites this paper
• The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus

  2009cites this paper
• Transdermal buprenorphine – a critical appraisal of its role in pain management

  2009cites this paper
• Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

  2009influential citation
• Types of Cancer Pain Examples of neuropathic pain Tumor compression of plexi Tumor invasion into nerves Tumor invasion into spinal cord Chemotherapy-induced neuritis Radiation-induced nerve injury Examples of somatic / nociceptive pain Tumor invasion into bone

  2008cites this paper
• Cancer Pain and Analgesia

  2008cites this paper
• Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.

  2008cites this paper
• Current concepts of pain management for cancer patients

  2008cites this paper
• Management of chronic pain in the elderly: focus on transdermal buprenorphine

  2008cites this paper
• Transdermal buprenorphine in chronic pain: indications and clinical experience

  2008cites this paper
• The Pharmacologic Management of Cancer Pain

  2007cites this paper
• Cholestasis and Endogenous Opioids

  2007cites this paper
• Buprenorfina w leczeniu bólu

  2007cites this paper
• Co powinniúmy wiedzieÊ o stosowaniu lekÛw opioidowych u pacjentÛw z przewlek‡" chorob" nerek?

  2007cites this paper
• Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know.

  2007cites this paper
• Transdermal buprenorphine in the management of persistent pain – safety aspects

  2006cites this paper
• Renal impairment: a challenge for opioid treatment? The role of buprenorphine

  2006cites this paper
• Management of Cancer Pain

  2006cites this paper